← Leaderboards
Alexandra Toporek
Johns Hopkins University
$165,400
Attributed
$165,400
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $89K · FY2021–22$100K$75K$50K$25K$0
'21
'22
Funding mix
By agency
NIH$165,400 · 1
By mechanism
F32$165,400 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Meredith C McCormack$14,784,022
- Robert P Schleimer$28,154,309
- Garry R Cutting$22,692,645
- Nadia N Hansel$30,283,781
- Michael Bradley Drummond$10,950,193
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAdherenceAdultAffectAirway Surface LiquidAllelesAntibioticsAntibiotic TherapyAzithromycinBody SystemBronchiectasisCaringCaucasiansChloridesChronicChronic InfectionClinical CareClinical DataCohortConsumptionCystic FibrosisCystic Fibrosis PatientsCystic Fibrosis Transmembrane Conductance RegulatorAccreditation
Grant awards (2)
Changes in Provider Practices for the Management of Cystic Fibrosis (CF) in the Era of Highly Effective Modulator Therapy$76,442
F32 · FY2022 · HL · contact PI
Changes in Provider Practices for the Management of Cystic Fibrosis (CF) in the Era of Highly Effective Modulator Therapy$88,958
F32 · FY2021 · HL · contact PI